Visual Universitätsmedizin Mainz

Pre-clinical molecular (optical non-invasive 3D in vivo small animal) imaging (Danckwardt Group)

We apply preclinical molecular optical imaging to monitor dynamic (disease) processes non-invasively in living organisms (as well as ex vivo in human specimens). By using molecular labelling strategies and genetically modified animals we visualize a wide spectrum of molecular events and processes in cells, tissues, organs and the whole body of living organisms in T&H research and beyond (such as vascularization and neoangiogensis, vessel integrity, cell tracking, infiltration of immune and tumor cells, bacteria, inflammation, infection, metabolism, hypoxia, glucose-metabolism). Preclinical molecular imaging thus constitutes a “diagnostic” continuum beyond other in vitro, ex vivo and invasive in vivo imaging modalities to close the gap between basic insights obtained by experimental research and the clinical understanding of complex disease mechanisms and potentially new therapeutic targets.

"Preclinical Optical Imaging" - Danckwardt lab (Pdf-file, 2,9 MB)

Should you have any question or face challenges where you think we could help with our technology, please do not hesitate to get in touch with us!

Further references

  • Steven S, Jurk K, Kopp M, Kröller-Schön S, Mikhed Y, Schwierczek K, Roohani S, Kashani F, Oelze M, Klein T, Tokalov S, Danckwardt S, Strand S, Wenzel P, Münzel T, Daiber A. Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitrosative and oxidative stress, systemic inflammation and platelet activation in endotoxaemic mice. British journal of pharmacology. 2016.
  • Tokalov & Danckwardt, available upon request
  • Tokalov et al. Chest, 2012
  • Tokalov et al. ESKS Baumann M. (Ed.), Hamburg, Germany 2012


Professor Sven Danckwardt, MD

Head of the Professorship ''Experimental Hemostasis and Laboratory Medicine'' (Module A); DZHK Scientist

Phone 06131/ 17-6041 or 17-2632
Fax    06131/ 17-5588